article thumbnail

Covid vaccine booster raises antibody levels in fight against Omicron

pharmaphorum

A third dose of vaccine has been shown to effectively neutralise the Omicron variant of covid-19, according to researchers. In people who had received the Pfizer/BioNTech vaccine for all three doses, antibody levels against Omicron after a third dose were similar to those previously reached against Delta after only two doses.

Antibody 115
article thumbnail

Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?

XTalks

A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. In the trial, the vaccine was injected directly into the lymph nodes of type 1 diabetic individuals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Implementing rapid microbial identification in biotherapy manufacturing

Drug Discovery World

Regulatory agencies consider genotypic identification to be more reliable than phenotypic methods. Per regulatory guidelines, the implementation of an environmental monitoring programme is required to comply with good manufacturing practices and identification of microorganisms to species level is a minimal requirement.

article thumbnail

Webinar: Environmental monitoring within biotherapeutic production

Drug Discovery World

Regulatory agencies consider genotypic identification to be more reliable than phenotypic methods. Per regulatory guidelines, the implementation of an environmental monitoring programme is required to comply with good manufacturing practices and identification of microorganisms to species level is a minimal requirement.

article thumbnail

Webinar: Understand microbial control in biotherapy production

Drug Discovery World

Regulatory agencies consider genotypic identification to be more reliable than phenotypic methods. Per regulatory guidelines, the implementation of an environmental monitoring programme is required to comply with good manufacturing practices and identification of microorganisms to species level is a minimal requirement.

article thumbnail

Webinar: The importance of microbial identification in biotherapy manufacturing

Drug Discovery World

Regulatory agencies consider genotypic identification to be more reliable than phenotypic methods. Per regulatory guidelines, the implementation of an environmental monitoring programme is required to comply with good manufacturing practices and identification of microorganisms to species level is a minimal requirement.

article thumbnail

Webinar: Enhancing quality control in biotherapy manufacturing

Drug Discovery World

Regulatory agencies consider genotypic identification to be more reliable than phenotypic methods. Per regulatory guidelines, the implementation of an environmental monitoring programme is required to comply with good manufacturing practices and identification of microorganisms to species level is a minimal requirement.